비교리스트

 카트 문의
시장보고서
상품코드
1605900

타깃 DNA/RNA 시퀀싱 시장 규모, 점유율, 동향, 산업 분석 리포트 : 유형별, 메소드별, 워크플로우별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Targeted DNA RNA Sequencing Market Size, Share, Trends, Industry Analysis Report: By Type, Method, Workflow, End User, and Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 타깃 DNA/RNA 시퀀싱 시장 규모는 2034년까지 707억 9,000만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트를 제공하고, 향후 시장 성장에 관한 분석을 제공하고 있습니다.

타깃 DNA/RNA 시퀀싱 시장은 차세대 염기서열 분석(NGS) 기술의 발전, 맞춤형 의료에 대한 수요 증가, 유전성 질환 및 암의 유병률 증가에 힘입어 강력한 성장세를 보이고 있습니다. 이 시장은 신약개발, 동반진단, 임상현장에서의 시퀀싱 적용 확대 등의 기회를 통해 이익을 얻고 있습니다.

데이터 분석을 위한 AI와 바이오인포매틱스의 통합, 비용 효율적인 시퀀싱 플랫폼의 개발, 단일 세포 시퀀싱에 대한 관심 증가는 예측 기간 중 시장의 주요 동향으로 부상할 것으로 예상됩니다. 전반적으로 지속적인 기술 혁신과 정밀의료의 광범위한 도입에 힘입어 시장은 크게 성장할 것으로 예상됩니다.

표적 DNA/RNA 시퀀싱 시장 보고서 하이라이트

유형별로는 DNA 기반 부문이 임상 진단 및 연구에 광범위하게 적용되어 시장을 주도하고 있으며, RNA 기반 부문은 전사체학 및 유전자 발현 연구에서의 사용 증가로 인해 급속한 성장세를 보이고 있습니다.

엑솜 시퀀싱 분야는 질병과 관련된 유전자 변이를 식별하는 데 널리 사용되고 있으며, 기술별로 시장을 선도하고 있습니다. 그러나 암 연구 분야에서는 비용 효율성과 표적화 접근법으로 인해 암 연구 분야에서 앰플리컨시퀀싱 분야가 특히 각광을 받고 있습니다.

워크플로우 측면에서는 기술 발전과 비용 절감의 혜택을 누리고 있는 시퀀싱 부문이 가장 큰 시장 점유율을 차지하고 있습니다. 데이터 분석은 복잡한 시퀀싱 데이터를 처리하기 위한 강력한 생물정보학 툴의 필요성에 힘입어 가장 빠르게 성장하고 있는 분야입니다.

최종사용자별로는 유전체 연구의 진행과 연구비 지출로 인해 학술연구 분야가 가장 큰 시장 점유율을 차지하고 있습니다. 제약 및 생명공학 기업 부문은 가장 빠르게 성장하고 있는 분야로, 의약품 개발 및 맞춤형 의료에 시퀀싱을 활용하고 있습니다.

북미는 첨단인 헬스케어 인프라와 대규모 R&D 투자로 시장을 주도하고 있습니다. 아시아태평양은 중국, 인도 등 신흥 경제권에서 시퀀싱 기술 채택이 증가하면서 가장 빠르게 성장하고 있는 지역입니다.

목차

제1장 서론

제2장 개요

제3장 조사 방법

제4장 세계의 타깃 DNA/RNA 시퀀싱 시장 인사이트

  • 시장 스냅숏
  • 타깃 DNA/RNA 시퀀싱 시장 역학
    • 촉진요인과 기회
      • 시퀀싱 기술의 진보
      • 종양학 조사의 확대
    • 억제요인과 과제
      • 어세이 설계를 위한 고비용으로 집중적인 프로세스.
  • PESTEL 분석
  • 타깃 DNA/RNA 시퀀싱 시장의 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 타깃 DNA/RNA 시퀀싱 시장 : 유형별

  • 주요 조사 결과
  • 서론
  • DNA 기반
  • RNA 기반

제6장 세계의 타깃 DNA/RNA 시퀀싱 시장 : 메소드별

  • 주요 조사 결과
  • 서론
  • 엑솜 시퀀싱
  • 인리치먼트 시퀀싱
  • 앰플리콘 시퀀싱
  • 기타

제7장 세계의 타깃 DNA/RNA 시퀀싱 시장 : 워크플로우별

  • 주요 조사 결과
  • 서론
  • 사전 시퀀싱
  • 시퀀싱
  • 데이터 분석

제8장 세계의 타깃 DNA/RNA 시퀀싱 시장 : 최종사용자별

  • 주요 조사 결과
  • 서론
  • 학술 조사
  • 병원·클리닉
  • 제약 및 바이오테크놀러지 기업
  • 기타

제9장 세계의 타깃 DNA/RNA 시퀀싱 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 타깃 DNA/RNA 시퀀싱 시장 평가 : 지역, 2020-2034년
  • 북미
    • 북미 : 유형별, 2020-2034년
    • 북미 : 메소드별, 2020-2034년
    • 북미 : 워크플로우별, 2020-2034년
    • 북미 : 최종사용자별, 2020-2034년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 유형별, 2020-2034년
    • 유럽 : 메소드별, 2020-2034년
    • 유럽 : 워크플로우별, 2020-2034년
    • 유럽 : 최종사용자별, 2020-2034년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 유형별, 2020-2034년
    • 아시아태평양 : 메소드별, 2020-2034년
    • 아시아태평양 : 워크플로우별, 2020-2034년
    • 아시아태평양 : 최종사용자별, 2020-2034년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 유형별, 2020-2034년
    • 중동 및 아프리카 : 메소드별, 2020-2034년
    • 중동 및 아프리카 : 워크플로우별, 2020-2034년
    • 중동 및 아프리카 : 최종사용자별, 2020-2034년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 유형별, 2020-2034년
    • 라틴아메리카 : 메소드별, 2020-2034년
    • 라틴아메리카 : 워크플로우별, 2020-2034년
    • 라틴아메리카 : 최종사용자별, 2020-2034년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제11장 기업 개요

  • Illumina Inc.
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Roche Sequencing Solutions
  • QIAGEN
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • BGI Genomics
  • Genomatix Software
  • Bio-Rad Laboratories
  • PerkinElmer
  • Hudon Alpha
  • Element Biosciences
  • Twist Bioscience
  • Nextera
KSA 25.01.06

The global targeted DNA RNA sequencing market size is expected to reach USD 70.79 billion by 2034, according to a new study by Polaris Market Research. The report "Targeted DNA RNA Sequencing Market Size, Share, Trends, Industry Analysis Report: By Type (DNA-Based and RNA-Based), Method, Workflow, End User (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted DNA/RNA sequencing market is experiencing robust growth, driven by advancements in next-generation sequencing (NGS) technologies, increasing demand for personalized medicine, and the rising prevalence of genetic disorders and cancer. The market benefits from opportunities in drug discovery, companion diagnostics, and the expanding application of sequencing in clinical settings.

The integration of AI and bioinformatics for data analysis, the development of cost-effective sequencing platforms, and growing interest in single-cell sequencing are expected to emerge as key trends in the market during the forecast period. Overall, the market is set for substantial expansion, underpinned by continuous innovation and the broader adoption of precision medicine.

Targeted DNA RNA Sequencing Market Report Highlights

Based on type, the DNA-based segment dominates the market due to its extensive application in clinical diagnostics and research. The RNA-based segment is witnessing rapid growth, driven by its increasing use in transcriptomics and gene expression studies.

The exome sequencing segment, by method, leads the market, as it is widely adopted for identifying genetic variations linked to diseases. However, the amplicon sequencing segment is gaining traction for its cost-effectiveness and targeted approach, particularly in cancer research.

The sequencing segment, in terms of workflow, holds the largest market share, benefiting from technological advancements and reduced costs. Data analysis is the fastest-growing segment, propelled by the need for robust bioinformatics tools to handle complex sequencing data.

By end user, the academic research segment holds the largest market share due to ongoing genomic studies and research funding. The pharma & biotech entities segment is the fastest-growing segment, leveraging sequencing for drug development and personalized medicine.

North America dominates the market, driven by advanced healthcare infrastructure and significant R&D investments. Asia Pacific is the fastest-growing region, with increasing adoption of sequencing technologies in emerging economies such as China and India.

Polaris Market Research has segmented the targeted DNA RNA sequencing market report on the basis of type, method, workflow, end user, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • DNA-Based
  • RNA-Based

By Method Outlook (Revenue - USD Billion, 2020-2034)

  • Exome Sequencing
  • Enrichment Sequencing
  • Amplicon Sequencing
  • Others

By Workflow Outlook (Revenue - USD Billion, 2020-2034)

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By End User Outlook (Revenue - USD Billion, 2020-2034)

  • Academic Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Targeted DNA RNA Sequencing Market Insights

  • 4.1. Targeted DNA RNA Sequencing Market - Market Snapshot
  • 4.2. Targeted DNA RNA Sequencing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Sequencing Technologies
      • 4.2.1.2. Expansion in Oncology Research
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high cost and intensive process for assay design.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Targeted DNA RNA Sequencing Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Targeted DNA RNA Sequencing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. DNA-Based
    • 5.3.1. Global Targeted DNA RNA Sequencing Market, by DNA-Based, by Region, 2020-2034 (USD Billion)
  • 5.4. RNA-Based
    • 5.4.1. Global Targeted DNA RNA Sequencing Market, by RNA-Based, by Region, 2020-2034 (USD Billion)

6. Global Targeted DNA RNA Sequencing Market, by Method

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  • 6.3. Exome Sequencing
    • 6.3.1. Global Targeted DNA RNA Sequencing Market, by Exome Sequencing, by Region, 2020-2034 (USD Billion)
  • 6.4. Enrichment Sequencing
    • 6.4.1. Global Targeted DNA RNA Sequencing Market, by Enrichment Sequencing, by Region, 2020-2034 (USD Billion)
  • 6.5. Amplicon Sequencing
    • 6.5.1. Global Targeted DNA RNA Sequencing Market, by Amplicon Sequencing, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Targeted DNA RNA Sequencing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Targeted DNA RNA Sequencing Market, by Workflow

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  • 7.3. Pre-sequencing
    • 7.3.1. Global Targeted DNA RNA Sequencing Market, by Pre-sequencing, by Region, 2020-2034 (USD Billion)
  • 7.4. Sequencing
    • 7.4.1. Global Targeted DNA RNA Sequencing Market, by Sequencing, by Region, 2020-2034 (USD Billion)
  • 7.5. Data Analysis
    • 7.5.1. Global Targeted DNA RNA Sequencing Market, by Data Analysis, by Region, 2020-2034 (USD Billion)

8. Global Targeted DNA RNA Sequencing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
  • 8.3. Academic Research
    • 8.3.1. Global Targeted DNA RNA Sequencing Market, by Academic Research, by Region, 2020-2034 (USD Billion)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Global Targeted DNA RNA Sequencing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 8.5. Pharma & Biotech Entities
    • 8.5.1. Global Targeted DNA RNA Sequencing Market, by Pharma & Biotech Entities, by Region, 2020-2034 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global Targeted DNA RNA Sequencing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Targeted DNA RNA Sequencing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Targeted DNA RNA Sequencing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Targeted DNA RNA Sequencing Market - North America
    • 9.3.1. North America: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
    • 9.3.3. North America: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.3.4. North America: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.3.5. Targeted DNA RNA Sequencing Market - US
      • 9.3.5.1. US: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.3.6. Targeted DNA RNA Sequencing Market - Canada
      • 9.3.6.1. Canada: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
  • 9.4. Targeted DNA RNA Sequencing Market - Europe
    • 9.4.1. Europe: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.5. Targeted DNA RNA Sequencing Market - UK
      • 9.4.5.1. UK: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.6. Targeted DNA RNA Sequencing Market - France
      • 9.4.6.1. France: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.7. Targeted DNA RNA Sequencing Market - Germany
      • 9.4.7.1. Germany: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.8. Targeted DNA RNA Sequencing Market - Italy
      • 9.4.8.1. Italy: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.9. Targeted DNA RNA Sequencing Market - Spain
      • 9.4.9.1. Spain: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.10. Targeted DNA RNA Sequencing Market - Netherlands
      • 9.4.10.1. Netherlands: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.11. Targeted DNA RNA Sequencing Market - Russia
      • 9.4.11.1. Russia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.4.12. Targeted DNA RNA Sequencing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
  • 9.5. Targeted DNA RNA Sequencing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.5. Targeted DNA RNA Sequencing Market - China
      • 9.5.5.1. China: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.6. Targeted DNA RNA Sequencing Market - India
      • 9.5.6.1. India: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.7. Targeted DNA RNA Sequencing Market - Malaysia
      • 9.5.7.1. Malaysia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.8. Targeted DNA RNA Sequencing Market - Japan
      • 9.5.8.1. Japan: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.9. Targeted DNA RNA Sequencing Market - Indonesia
      • 9.5.9.1. Indonesia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.10. Targeted DNA RNA Sequencing Market - South Korea
      • 9.5.10.1. South Korea: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.11. Targeted DNA RNA Sequencing Market - Australia
      • 9.5.11.1. Australia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.5.12. Targeted DNA RNA Sequencing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
  • 9.6. Targeted DNA RNA Sequencing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.5. Targeted DNA RNA Sequencing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.6. Targeted DNA RNA Sequencing Market - UAE
      • 9.6.6.1. UAE: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.7. Targeted DNA RNA Sequencing Market - Israel
      • 9.6.7.1. Israel: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.8. Targeted DNA RNA Sequencing Market - South Africa
      • 9.6.8.1. South Africa: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.6.9. Targeted DNA RNA Sequencing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
  • 9.7. Targeted DNA RNA Sequencing Market - Latin America
    • 9.7.1. Latin America: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.5. Targeted DNA RNA Sequencing Market - Mexico
      • 9.7.5.1. Mexico: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.6. Targeted DNA RNA Sequencing Market - Brazil
      • 9.7.6.1. Brazil: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.7. Targeted DNA RNA Sequencing Market - Argentina
      • 9.7.7.1. Argentina: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
    • 9.7.8. Targeted DNA RNA Sequencing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Illumina Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Thermo Fisher Scientific
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Agilent Technologies
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Roche Sequencing Solutions
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. QIAGEN
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Pacific Biosciences
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Oxford Nanopore Technologies
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. BGI Genomics
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Genomatix Software
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Bio-Rad Laboratories
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. PerkinElmer
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Hudon Alpha
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Element Biosciences
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Twist Bioscience
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Nextera
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제